Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Upstream Bio, Inc., Common Stock

UPB

NSQ

$19.01

-$1.24

(-6.12%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

595.16K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$17 L

$29.46 H

$19.01

About Upstream Bio, Inc., Common Stock

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts. more

Returns

Data is not properly formatted.

Time Frame	UPB		S&P500
1-Week Return	-14.37%%	%	-0.05%%
1-Month Return	-20.03%%	%	2.75%%
3-Month Return	11.82%%	%	7.4%%

Financials

	Dec '22	Dec '23
Total Revenue	1.21M	2.38M	[{"date":"2022-12-31","value":50.92,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	25.12M	42.49M	[{"date":"2022-12-31","value":59.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	(23.91M)	(40.11M)	[{"date":"2022-12-31","value":-2390900000,"profit":false},{"date":"2023-12-31","value":-4011400000,"profit":false}]
Total Non-Operating Income/Expense	41.00K	19.58M	[{"date":"2022-12-31","value":0.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	(23.87M)	(20.54M)	[{"date":"2022-12-31","value":-2386800000,"profit":false},{"date":"2023-12-31","value":-2053700000,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(23.87M)	(20.54M)	[{"date":"2022-12-31","value":-2386800000,"profit":false},{"date":"2023-12-31","value":-2053700000,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(23.87M)	(20.54M)	[{"date":"2022-12-31","value":-2386800000,"profit":false},{"date":"2023-12-31","value":-2053700000,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

	Dec '22	Dec '23
Total Revenue	-	96.37%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	-	69.16%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	-	67.78%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	47648.78%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	-	(13.96%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(13.96%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(13.96%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Dec '22	Dec '23
Total Assets
Current Assets	18.31M	117.00M	[{"date":"2022-12-31","value":15.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	171.00K	202.00K	[{"date":"2022-12-31","value":84.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	18.48M	117.20M	[{"date":"2022-12-31","value":15.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	4.86M	6.51M	[{"date":"2022-12-31","value":74.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	119.78M	233.81M	[{"date":"2022-12-31","value":51.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	124.63M	240.32M	[{"date":"2022-12-31","value":51.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	(107.44M)	(127.97M)	[{"date":"2022-12-31","value":-10743700000,"profit":false},{"date":"2023-12-31","value":-12797400000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	(106.16M)	(123.13M)	[{"date":"2022-12-31","value":-10615500000,"profit":false},{"date":"2023-12-31","value":-12312600000,"profit":false}]

Total Liabilities & Shareholders Equity	18.48M	117.20M	[{"date":"2022-12-31","value":15.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	-	539.08%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	18.13%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	-	534.26%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	34.16%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	-	95.20%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	92.83%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	19.12%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	15.99%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	534.26%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]


Total Assets
Current Assets	[]
Non-current Assets	[]
Total Assets	[]

Total Liabilities
Current Liabilities	[]
Non-current Liabilities	[]
Total Liabilities	[]

Total Shareholders' equity
Common Stock	[]
Retained Earnings	[]
Other Stockholders' Equity	[]
Total Shareholders' equity	[]

Total Liabilities & Shareholders Equity	[]


Total Assets
Current Assets	[]
Non-current Assets	[]
Total Assets	[]

Total Liabilities
Current Liabilities	[]
Non-current Liabilities	[]
Total Liabilities	[]

Total Shareholders' equity
Common Stock	[]
Retained Earnings	[]
Other Stockholders' Equity	[]
Total Shareholders' equity	[]

Total Liabilities & Shareholders Equity	[]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	(19.02M)	(37.93M)	[{"date":"2022-12-31","value":-1902100000,"profit":false},{"date":"2023-12-31","value":-3792600000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	9.96M	129.55M	[{"date":"2022-12-31","value":7.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	(9.14M)	8.78M	[{"date":"2022-12-31","value":-104.08,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(19.10M)	(38.07M)	[{"date":"2022-12-31","value":-1910300000,"profit":false},{"date":"2023-12-31","value":-3807000000,"profit":false}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	-	99.39%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	1200.31%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	-	(196.08%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	99.29%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	UPB
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	UPB
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Upstream Bio, Inc. share price today?

Upstream Bio, Inc. (UPB) share price today is $19.01

Can Indians buy Upstream Bio, Inc. shares?

Yes, Indians can buy shares of Upstream Bio, Inc. (UPB) on Vested. To buy Upstream Bio, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in UPB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Upstream Bio, Inc. be purchased?

Yes, you can purchase fractional shares of Upstream Bio, Inc. (UPB) via the Vested app. You can start investing in Upstream Bio, Inc. (UPB) with a minimum investment of $1.

How to invest in Upstream Bio, Inc. shares from India?

You can invest in shares of Upstream Bio, Inc. (UPB) via Vested in three simple steps:

Click on Sign Up or Invest in UPB stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Upstream Bio, Inc. shares

What is Upstream Bio, Inc. 52-week high and low stock price?

The 52-week high price of Upstream Bio, Inc. (UPB) is $29.46. The 52-week low price of Upstream Bio, Inc. (UPB) is $17.

What is Upstream Bio, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Upstream Bio, Inc. (UPB) is

What is Upstream Bio, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Upstream Bio, Inc. (UPB) is 0.00

What is Upstream Bio, Inc. dividend yield?

The dividend yield of Upstream Bio, Inc. (UPB) is 0.00%

What is the Market Cap of Upstream Bio, Inc.?

The market capitalization of Upstream Bio, Inc. (UPB) is

What is Upstream Bio, Inc.’s stock symbol?

The stock symbol (or ticker) of Upstream Bio, Inc. is UPB